BioCryst's total assets for Q4 2025 were $514.16M, an increase of 15.17% from the previous quarter. BCRX total liabilities were $633.31M for the fiscal quarter, a -24.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.